BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2889412)

  • 1. Alterations in selected serum biochemical constituents in equids after induced hepatic disease.
    Hoffmann WE; Baker G; Rieser S; Dorner JL
    Am J Vet Res; 1987 Sep; 48(9):1343-7. PubMed ID: 2889412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma bile acid elevation following CCI4 induced liver damage in dogs, sheep, calves and ponies.
    Anwer MS; Engelking LR; Gronwall R; Klentz RD
    Res Vet Sci; 1976 Mar; 20(2):127-30. PubMed ID: 1265349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical chemical constituents in relation to liver amyloidosis in serum-producing horses.
    Abdelkader SV; Gudding R; Nordstoga K
    J Comp Pathol; 1991 Aug; 105(2):203-11. PubMed ID: 1685737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A screening test for subclinical liver disease in horses affected by pyrrolizidine alkaloid toxicosis.
    Curran JM; Sutherland RJ; Peet RL
    Aust Vet J; 1996 Sep; 74(3):236-40. PubMed ID: 8894041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid concentrations in the diagnosis of hepatobiliary disease in the cat.
    Center SA; Baldwin BH; Erb H; Tennant BC
    J Am Vet Med Assoc; 1986 Oct; 189(8):891-6. PubMed ID: 3771358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of total plasma bile acid concentrations for the diagnosis of hepatobiliary disease in horses.
    West HJ
    Res Vet Sci; 1989 Mar; 46(2):264-70. PubMed ID: 2565044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
    Center SA; ManWarren T; Slater MR; Wilentz E
    J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute experimentally induced aflatoxicosis in the weanling pony.
    Bortell R; Asquith RL; Edds GT; Simpson CF; Aller WW
    Am J Vet Res; 1983 Nov; 44(11):2110-4. PubMed ID: 6139967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bile acids concentrations in healthy and clinically ill neonatal foals.
    Barton MH; LeRoy BE
    J Vet Intern Med; 2007; 21(3):508-13. PubMed ID: 17552459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bile acids and other liver function tests in hepatocellular damage from carbon tetrachloride ingestion.
    Campbell CB; Collins DM; Van Tongeren A
    N Z Med J; 1980 May; 91(660):381-4. PubMed ID: 6157137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum bile acids concentrations for diagnosis of hepatobiliary disease in cats.
    Center SA; Erb HN; Joseph SA
    J Am Vet Med Assoc; 1995 Oct; 207(8):1048-54. PubMed ID: 7559044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipid and lipoprotein changes in ponies with experimentally induced liver disease.
    Bauer JE; Meyer DJ; Campbell M; McMurphy R
    Am J Vet Res; 1990 Sep; 51(9):1380-4. PubMed ID: 2396785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations of plasma enzymes in the pony and the dog after carbon tetrachloride administration.
    Noonan NE
    Am J Vet Res; 1981 Apr; 42(4):674-8. PubMed ID: 7332128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic efficacy of serum alkaline phosphatase and gamma-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980-1990).
    Center SA; Slater MR; Manwarren T; Prymak K
    J Am Vet Med Assoc; 1992 Oct; 201(8):1258-64. PubMed ID: 1358870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum gamma-glutamyl transpeptidase activity in healthy cats and cats with induced hepatic disease.
    Spano JS; August JR; Henderson RA; Dumas MB; Groth AH
    Am J Vet Res; 1983 Nov; 44(11):2049-53. PubMed ID: 6139966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical semiology of the liver in ruminants].
    Braun JP; Bézille P; Rico AG
    Reprod Nutr Dev (1980); 1986; 26(1B):227-43. PubMed ID: 2871602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of plasma arginase and gamma-glutamyl transpeptidase as specific indicators of heptocellular or hepatobiliary disease in the dog.
    Noonan NE; Meyer DJ
    Am J Vet Res; 1979 Jul; 40(7):942-7. PubMed ID: 41466
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyrrolizidine alkaloid-induced liver disease in horses: an early diagnosis.
    Mendel VE; Witt MR; Gitchell BS; Gribble DN; Rogers QR; Segall HJ; Knight HD
    Am J Vet Res; 1988 Apr; 49(4):572-8. PubMed ID: 3377320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory assessment of hepatic injury in the woodchuck (Marmota monax).
    Hornbuckle WE; Graham ES; Roth L; Baldwin BH; Wickenden C; Tennant BC
    Lab Anim Sci; 1985 Aug; 35(4):376-81. PubMed ID: 2864472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological studies in horses with hepatic disease.
    West HJ
    Equine Vet J; 1996 Mar; 28(2):146-56. PubMed ID: 8706647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.